Iveric Bio Inc (NASDAQ:ISEE)
| 3.51 Delayed Data As of 4:00pm ET |  +0.04 / +1.15%Today’s Change | 0.91 Today|||52-Week Range 8.97 | -59.09% Year-to-Date |
Latest ISEE News | Press Releases
No recent news for Iveric Bio Inc.
Today’s Trading
| Previous close | 3.47 |
| Today’s open | 3.55 |
| Day’s range | 3.47 - 3.59 |
| Volume | 17,972 |
| Average volume (3 months) | 759,038 |
| Market cap | $172.4M |
Data as of 4:00pm ET, 03/30/2020
Growth & Valuation
| Earnings growth (last year) | -181.89% |
| Earnings growth (this year) | +2.88% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.47 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABEOAbeona Therapeutics ... | -0.04 | -1.69% |
| EIGREiger BioPharmaceuti... | -0.29 | -4.15% |
| MNLOMenlo Therapeutics I... | -0.27 | -9.22% |
| SLGLSol Gel Technologies... | -0.61 | -8.02% |
Data as of 3:59pm ET, 03/30/2020
Financials
| Next reporting date | April 29, 2020 |
| EPS forecast (this quarter) | -$0.34 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$58.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
